Clinical Trials Directory

Trials / Completed

CompletedNCT02290600

Feasibility Study Using Run-to-Run Control to Optimize Continuous Glucose Sensor Bias

Status
Completed
Phase
Study type
Observational
Enrollment
23 (actual)
Sponsor
Sansum Diabetes Research Institute · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of this 12 week feasibility study is to see how much more accurate a continuous glucose monitor (CGM) might be in individuals with type 1 diabetes if the investigators personalize sensor calibrations to the user, based on previous wear.

Detailed description

The purpose of this 12 week study is to see how much more accurate a continuous glucose monitor (CGM) might be if we personalize the sensor calibration algorithm for each individual. The calibration algorithm is a mathematical calculation built into the CGM. Currently, the CGM asks for a regular blood test (finger stick) measurement twice a day in order to make its calibration algorithm more accurate. Our goal is to keep refining the calculating ability so that it will provide personalized blood sugar control throughout the day for each individual using the sensor with the CGM.

Conditions

Interventions

TypeNameDescription
DEVICEContinuous Glucose MonitorCGM sensor calibration individualization

Timeline

Start date
2015-01-01
Primary completion
2016-10-01
Completion
2016-12-01
First posted
2014-11-14
Last updated
2018-07-12

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02290600. Inclusion in this directory is not an endorsement.